DAMANTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 24.724
AS - Asia 9.233
EU - Europa 6.268
SA - Sud America 1.562
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 8
Totale 42.070
Nazione #
US - Stati Uniti d'America 24.416
SG - Singapore 4.316
CN - Cina 1.858
UA - Ucraina 1.473
BR - Brasile 1.221
DE - Germania 1.020
HK - Hong Kong 878
IT - Italia 835
VN - Vietnam 780
FI - Finlandia 606
RU - Federazione Russa 597
FR - Francia 400
SE - Svezia 329
IN - India 311
IE - Irlanda 298
GB - Regno Unito 266
TR - Turchia 254
CA - Canada 173
AR - Argentina 133
KR - Corea 103
BD - Bangladesh 92
IR - Iran 83
IQ - Iraq 81
JP - Giappone 81
ZA - Sudafrica 77
MX - Messico 74
BE - Belgio 70
PK - Pakistan 66
PL - Polonia 64
EC - Ecuador 58
NL - Olanda 56
AT - Austria 48
SA - Arabia Saudita 45
ES - Italia 43
ID - Indonesia 43
CO - Colombia 37
CZ - Repubblica Ceca 30
UZ - Uzbekistan 30
EG - Egitto 28
MA - Marocco 28
PH - Filippine 28
PY - Paraguay 28
VE - Venezuela 28
AE - Emirati Arabi Uniti 24
CL - Cile 24
RO - Romania 24
KE - Kenya 23
TG - Togo 22
EU - Europa 19
IL - Israele 16
JO - Giordania 16
RS - Serbia 16
TN - Tunisia 16
UY - Uruguay 16
AZ - Azerbaigian 14
LT - Lituania 14
MY - Malesia 14
BH - Bahrain 12
DZ - Algeria 12
LB - Libano 12
NP - Nepal 12
DO - Repubblica Dominicana 11
JM - Giamaica 11
KZ - Kazakistan 10
PA - Panama 10
PS - Palestinian Territory 10
XK - ???statistics.table.value.countryCode.XK??? 10
BG - Bulgaria 9
ET - Etiopia 9
TH - Thailandia 9
AU - Australia 8
HU - Ungheria 8
PE - Perù 8
AL - Albania 7
CH - Svizzera 7
HR - Croazia 7
GR - Grecia 6
LV - Lettonia 6
SN - Senegal 6
TW - Taiwan 6
BO - Bolivia 5
OM - Oman 5
PT - Portogallo 5
CR - Costa Rica 4
DK - Danimarca 4
GA - Gabon 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MU - Mauritius 4
TT - Trinidad e Tobago 4
GT - Guatemala 3
HN - Honduras 3
LI - Liechtenstein 3
LU - Lussemburgo 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
Totale 42.019
Città #
Fairfield 2.753
Ashburn 2.201
Woodbridge 2.054
Singapore 1.932
Chandler 1.409
Houston 1.403
Seattle 1.181
Ann Arbor 1.107
Wilmington 1.035
Jacksonville 966
Cambridge 956
Beijing 872
Hong Kong 870
San Jose 749
Dearborn 626
Los Angeles 448
Chicago 439
Boardman 391
Udine 317
Lauterbourg 307
Dublin 294
Princeton 278
New York 264
Ho Chi Minh City 258
Munich 200
Salt Lake City 191
Izmir 187
Buffalo 169
The Dalles 153
Dallas 147
Hanoi 138
Hefei 133
San Diego 133
Council Bluffs 132
Helsinki 110
São Paulo 109
Seoul 95
Ogden 93
Tampa 90
Redmond 88
Redondo Beach 88
Des Moines 83
Elk Grove Village 83
Frankfurt am Main 83
Dong Ket 73
Turku 73
Santa Clara 71
Norwalk 69
Tokyo 69
Phoenix 68
Brussels 65
Sterling 58
Mumbai 56
Warsaw 56
Montreal 55
Orem 55
Columbus 54
Rio de Janeiro 47
San Mateo 47
Ottawa 46
Augusta 45
Chennai 45
Johannesburg 44
Kunming 44
Lancaster 41
Pittsburgh 41
Leawood 39
Trieste 39
Atlanta 38
Baghdad 38
London 37
Brooklyn 36
Denver 36
Düsseldorf 36
Stockholm 36
Belo Horizonte 35
Nanjing 35
Poplar 35
Grafing 33
Miami 33
Nuremberg 33
Falls Church 32
Washington 32
Ardabil 31
Da Nang 31
Milan 31
Amsterdam 30
Guangzhou 30
Toronto 30
Vienna 28
Mexico City 27
Tashkent 27
Ankara 26
Boston 25
Brasília 25
San Francisco 24
Dulles 23
Kansas City 23
Lomé 22
Quito 22
Totale 27.895
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.098
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 492
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 340
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 273
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 226
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 224
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 221
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 218
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 216
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 214
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 204
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 203
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 200
Expression of periostin in human breast cancer 200
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 198
Expression of differentiation markers in cultured cells from various thyroid diseases 197
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 197
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 192
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 191
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 191
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 191
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 191
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 190
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 189
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 187
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 185
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 185
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 185
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 185
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 184
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 184
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 183
Galectin-3 expression in non-small cell lung carcinoma 183
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 183
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 183
A molecular code dictates sequence-specific DNA recognition by homeodomains 182
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 180
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 179
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 178
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 178
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 177
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 174
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 174
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 173
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 173
Histone post-translational modifications associated to BAALC expression in leukemic cells. 173
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 173
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 173
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 172
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 171
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 171
Nucleophosmin is overexpressed in thyroid tumors 170
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 169
A differential proteomic approach to identify proteins associated with thyroid cell transformation 169
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 169
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 168
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 166
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 166
PAX8 expression in human bladder cancer. 166
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 166
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 165
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 164
A CGH array procedure to detect PAX6 gene structural defects 164
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 163
Homology model building of the thyroid transcription factor 1 homeodomain 161
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 160
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 160
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 159
Blood-brain barrier dysfunction in disorders of the developing brain 159
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 158
Differential proteomic analysis of nuclear extracts from thyroid cell lines 158
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 158
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 157
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 157
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 157
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 156
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 155
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 155
Thyroid-specific gene expression. 154
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 154
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 154
Molecular events in the differentiation of the thyroid gland 153
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 153
An 'environment to nucleus' signaling system operates in B lymphocytes: redox status 153
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 152
TSH controls ref-1 nuclear translocation in thyroid cells 151
Unexpected phenotype of a typical NPM1 mutant 151
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 150
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 150
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy 150
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. 149
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 149
Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation 148
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 148
Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: Evidence for an autoregulatory loop 147
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 146
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 146
Mitochondrial localization of APE/Ref-1 in thyroid cells 146
null 146
Thyroid defects due to Pax8 gene mutations 145
Totale 18.754
Categoria #
all - tutte 148.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021863 0 0 0 0 0 0 0 0 0 0 611 252
2021/20222.679 169 222 80 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/202612.613 1.362 2.339 996 1.272 1.789 925 1.493 338 907 1.027 165 0
Totale 42.669